Logo image
Se connecter
Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation (2445)
Article de revue   Avec comité de lecture

Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation (2445)

Michael Thorpy, Thomas Roth, Yves Dauvilliers, Clete Kushida, Colin Shapiro, Bruce Corser, Akinyemi Ajayi, Jordan Dubow, David Seiden et Russell Rosenberg
Neurology, Vol.96(15_supplement)
13/04/2021

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Logo image